Mobia Medical Reports Third Quarter 2026 Financial Results

Mobia Medical reported third-quarter 2026 revenue of $15.6 million, up 73% year over year, and gross profit of $13.0 million, up 81%, with an 83.2% gross margin. The company raised its 2026 revenue guidance to $57.0 million–$57.5 million from $54.0 million–$56.0 million, citing strong commercial performance and broader adoption of its Vivistim Paired VNS System. Operating expenses rose 71% to $31.5 million as Mobia invested in its commercial organization; cash and equivalents totaled $160.7 million at September 30.